Cabot Co. (NYSE:CBT) Shares Purchased by US Bancorp DE

US Bancorp DE increased its position in shares of Cabot Co. (NYSE:CBT) by 0.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 30,485 shares of the specialty chemicals company’s stock after acquiring an additional 267 shares during the period. US Bancorp DE owned approximately 0.06% of Cabot worth $3,407,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of CBT. Wolff Wiese Magana LLC acquired a new stake in Cabot during the 3rd quarter worth about $25,000. CWM LLC increased its position in Cabot by 60.6% in the 2nd quarter. CWM LLC now owns 416 shares of the specialty chemicals company’s stock worth $38,000 after buying an additional 157 shares during the period. UMB Bank n.a. increased its position in Cabot by 53.9% in the 3rd quarter. UMB Bank n.a. now owns 371 shares of the specialty chemicals company’s stock worth $41,000 after buying an additional 130 shares during the period. EverSource Wealth Advisors LLC increased its position in Cabot by 33.4% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 475 shares of the specialty chemicals company’s stock worth $48,000 after buying an additional 119 shares during the period. Finally, 1620 Investment Advisors Inc. bought a new position in Cabot in the 2nd quarter worth approximately $49,000. 93.18% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. JPMorgan Chase & Co. boosted their price target on Cabot from $95.00 to $105.00 and gave the company a “neutral” rating in a research note on Wednesday, August 7th. UBS Group decreased their price target on Cabot from $103.00 to $98.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 6th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, Cabot presently has a consensus rating of “Hold” and a consensus price target of $101.75.

Cabot Stock Up 1.0 %

Shares of Cabot stock opened at $110.09 on Tuesday. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.22 and a quick ratio of 1.45. The company has a market capitalization of $6.04 billion, a P/E ratio of 13.09, a price-to-earnings-growth ratio of 0.90 and a beta of 1.20. The business has a 50-day moving average of $108.20 and a two-hundred day moving average of $100.87. Cabot Co. has a 1 year low of $66.02 and a 1 year high of $117.14.

Cabot (NYSE:CBT) last posted its quarterly earnings data on Monday, August 5th. The specialty chemicals company reported $1.92 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.20. The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1 billion. Cabot had a return on equity of 26.99% and a net margin of 12.05%. The company’s revenue was up 5.0% on a year-over-year basis. During the same quarter last year, the company earned $1.42 EPS. As a group, equities analysts predict that Cabot Co. will post 7.07 EPS for the current year.

Insider Activity at Cabot

In other Cabot news, CEO Sean D. Keohane sold 25,617 shares of Cabot stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total transaction of $2,601,406.35. Following the transaction, the chief executive officer now directly owns 331,174 shares of the company’s stock, valued at approximately $33,630,719.70. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, EVP Jeff Ji Zhu sold 1,201 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $106.19, for a total transaction of $127,534.19. Following the transaction, the executive vice president now directly owns 96,000 shares of the company’s stock, valued at approximately $10,194,240. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Sean D. Keohane sold 25,617 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total value of $2,601,406.35. Following the completion of the sale, the chief executive officer now directly owns 331,174 shares of the company’s stock, valued at approximately $33,630,719.70. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 71,939 shares of company stock valued at $7,308,812 in the last 90 days. 3.07% of the stock is owned by corporate insiders.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.